Back to HSBC HOLDINGS PLC HSBC HOLDINGS PLC

EGRXEGRX
12 quarters

Position history for HSBC HOLDINGS PLCHSBC HOLDINGS PLC's holdings in EAGLE PHARMACEUTICALS INC

No. HSBC Holdings exited its EGRX (Eagle Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 11,396 shares worth $45,014. HSBC Holdings first reported EGRX in Q3 2019 and held it in 10 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$590,000

Total Shares Change

-10,421

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Decreased
11,396
-13.3%
$45,0140.0%$3.95
0
2024-Q2
Decreased
13,148
-0.2%
$66,2660.0%$5.60
0
2024-Q1
Increased
13,177
+9.8%
$69,0470.0%$5.24
16
2023-Q4
New
11,998
-
$62,9900.0%$5.23
29
2021-Q1
Exited
0
-100.0%
$00.0%$41.06
0
2020-Q4
Decreased
8,485
-5.4%
$394,0000.0%$46.50
0
2020-Q3
Increased
8,972
+17.7%
$381,0000.0%$41.88
28
2020-Q2
Increased
7,621
+73.8%
$366,0000.0%$48.02
36
2020-Q1
Decreased
4,386
-11.2%
$202,0000.0%$45.31
0
2019-Q4
Decreased
4,938
-52.6%
$297,0000.0%$59.89
0
2019-Q3
New
10,421
-
$590,0000.0%$56.43
34

Other major holders of EGRX: Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used